System and method for bronchial dilation

Inventors

Hlavka, Edwin J. • Elliott, Lynn

Assignees

Nuvaira Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-10252057-B2

Patent

Publication Date

2019-04-09

Expiration Date


Abstract

A method of reducing bronchial constriction in a subject includes delivering energy to create one or more lesions on a main bronchus so as to transect pulmonary nerves sufficiently to reduce bronchial constriction in a lung of the patient distal to the main bronchus.

Core Innovation

The disclosed system uses at least one electrode to deliver energy to tissue along a bronchus or trachea, or to a portion of the bronchi, under generator control to inhibit or reduce mucus production. The description also identifies bronchial nerve blocking intended to reduce smooth-muscle constriction and inhibit cough and mucus production. Therapy may be controlled using cough, mucus, activity, airway, or circadian information and paused to permit mucus clearance.

The system is directed to reducing mucus production, reducing smooth-muscle constriction, and inhibiting cough in a subject. Disclosed electrode configurations include bronchial patch, partial-cuff, full-cuff, and endobronchial arrangements. The generator controls energy delivery to tissue to block, inhibit, or reduce mucus production, while allowing therapy to be paused to permit mucus clearance.

Claims Coverage

The claim coverage includes two inventive features across two independent claims covering electrode-and-generator systems that deliver energy to bronchial or tracheal tissue to inhibit or reduce mucus production.

Energy delivery to bronchial or tracheal tissue to reduce mucus production

Claim 1 covers at least one electrode configured to deliver energy to tissue along a bronchus or trachea, with a generator configured to cause that delivery to block, inhibit, or reduce the subject's ability to produce mucus. The dependent claims add sensing, implantable nerve-signal blocking, therapy timing and delivery refinements, and stopping energy delivery upon detecting cessation of mucus production.

Energy delivery to bronchial tissue to inhibit or reduce mucus production

Claim 17 covers at least one electrode configured to deliver energy to tissue on at least a portion of the bronchi, with a generator configured to cause that delivery to inhibit or reduce mucus production. The dependent claim specifies blocking efferent signals that trigger mucus production.

The two independent claims cover energy delivery to bronchial or tracheal tissue to inhibit or reduce mucus production. Their dependent claims specify sensing and therapy-control refinements, nerve-signal blocking, and blocking efferent signals that trigger mucus production.

Stated Advantages

Not explicitly described in patent.

Documented Applications

Treatment of inflammation, hypertrophy, or constriction of smooth muscles lining the bronchi, or excessive mucus production.

Inhibiting or reducing mucus production by delivering energy to tissue on at least a portion of the bronchi.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.